Dr. Sandra Lee Husband Net Worth 2026#370 REAL ESTATE

Dermatologist

$0M
Likely $10M – $14M
Age59b. November 7, 1967
Active1990s - Presen
Main sourceDermatology Practifirst listed
Rank in field#370of 520 real estate
FromAmerican
Estimate, not a disclosed figureConfidence High(9/9 fields known)Band ±10%Last reviewed 30 July 2026How we estimate →

Where the money comes from

Dermatology Practice · primaryTelevisionSocial MediaReal Estate Investments

Listed in the order our sources give them; the first is treated as primary. We do not publish a percentage split — no public breakdown of this person’s income exists, and inventing one would be a guess.

Is $12M a lot? — against real estate

Ranked #370 of 520 real estate we hold an estimate for.

Dr. Sandra Lee, popularly known as Dr. Pimple Popper, has become a household name due to her captivating skin care videos and successful television show. While Dr. Lee enjoys public attention, her husband, Dr. Jeffrey Rebish, prefers to maintain a lower profile. In this article, we will explore Dr. Jeffrey Rebish’s net worth as of 2024, delving into his career, his role in their shared success, and the financial aspects of their lives together.

Dr. Jeffrey Rebish is not just Dr. Sandra Lee’s supportive spouse; he is also her professional partner. The duo has built a considerable fortune through their combined dermatology practice and other joint ventures.

As of 2024, Dr. Jeffrey Rebish’s net worth is estimated to be around $12 million, adjusted for inflation. This estimation takes into account his various sources of income, including his dermatology practice, television appearances, and social media involvement.

Considering their continuous ventures in dermatology and media, it can be expected that their net worth may grow further in the coming years, especially as they explore new business opportunities and projects.

Dr. Rebish's early education and career choices have significantly contributed to their current financial status. He attended prestigious institutions like Haverford College, Dartmouth College, and New York Medical College, setting a strong foundation for his career in dermatology.

The couple's dermatology practice is one of their primary sources of income, along with profitable ventures such as product lines and media presence. Their combined efforts have resulted in considerable financial success.

Dr. Rebish and Dr. Lee are known for their prudent financial management and strategic planning, which have been key to maintaining and growing their net worth. They have made wise investments in real estate and technology, contributing to their financial stability.

Despite their wealth, both Dr. Rebish and Dr. Lee are committed to giving back to the community. Their charitable contributions reflect their dedication to various causes and their desire to make a positive impact.

In modern terms, Dr. Rebish’s estimated net worth places him among the affluent professionals in the medical and media industry. Their combined financial standing continues to position them as influential figures in their respective fields.

The rise of social media and the success of their television show have provided a modern twist to their financial status. These platforms have opened new avenues for income and brand building, further enhancing their net worth.

Dr. Rebish co-owns their dermatology practice and supports various joint ventures and business endeavors.

His income stems from their dermatology practice, television show, social media revenue, product lines, and real estate investments.

The pandemic impacted global businesses, but they adapted by offering virtual consultations and focusing on their product lines, mitigating significant financial loss.

Yes, they actively participate in charitable work and have made significant donations to various causes.

AdvertisementIn-article · fluid
About this figureNet worth estimates on this site are compiled from public sources and comparable transactions. They are not audited, not confirmed by the subject, and will change. This page was last reviewed on 30 July 2026. Tell us if something is wrong.